Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434667 · ClinicalTrials.gov registry record · NA
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT01434667: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT01434667 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01434667, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
This study is intended to examine the impact of receiving a genetic risk assessment for Alzheimer's disease (AD) among individuals with Mild Cognitive Impairment (MCI).
Primary Outcome
A 15-item self-report assessment used to identify depression in the elderly. GDS scores ranged from 0-15. Higher scores indicated greater depression.
Interventions
- BEHAVIORAL APOE genotype and Alzheimer's disease risk disclosure
- BEHAVIORAL Alzheimer's disease risk disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01434667 record still lists
NCT01434667 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which APOE genotype and Alzheimer's disease risk disclosure is the first listed.
NCT01434667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01434667 about?
NCT01434667 is a clinical study titled "Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV". This study is intended to examine the impact of receiving a genetic risk assessment for Alzheimer's disease (AD) among individuals with Mild Cognitive Impairment (MCI).
What is the current status of trial NCT01434667?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2010-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01434667?
The interventions under investigation include: APOE genotype and Alzheimer's disease risk disclosure (BEHAVIORAL), Alzheimer's disease risk disclosure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01434667?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01434667's enrollment target sits among peer trials
146 704th of 2000 higher than 1,296 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia